Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection : interim results from the global NOBLE registry
- UPSpace Home
- →
- Health Sciences
- →
- Nuclear Medicine
- →
- Research Articles (Nuclear Medicine)
- →
- View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Tually, Pete
|
|
| dc.contributor.author | Quinto, Virginia G.
|
|
| dc.contributor.author | Omar, Yehia
|
|
| dc.contributor.author | Novruzov, Fuad
|
|
| dc.contributor.author | Yudistiro, Ryan
|
|
| dc.contributor.author | Sathekge, Mike Machaba
|
|
| dc.contributor.author | Currie, Geoffrey
|
|
| dc.contributor.author | Galette, Paul
|
|
| dc.contributor.author | Patel, Neel
|
|
| dc.contributor.author | Brown, Tracey
|
|
| dc.contributor.author | Bolland, Gabriel
|
|
| dc.contributor.author | Lo Bue, Rebecca
|
|
| dc.contributor.author | Cade, David
|
|
| dc.date.accessioned | 2025-02-13T06:02:42Z | |
| dc.date.available | 2025-02-13T06:02:42Z | |
| dc.date.issued | 2024-12 | |
| dc.description | DATA AVAILABITY STATEMENT: The datasets used and/or analyzed during the current study were provided within the manuscript and supplementary information files. | en_US |
| dc.description.abstract | Please read abstract in article. | en_US |
| dc.description.department | Nuclear Medicine | en_US |
| dc.description.sdg | SDG-03:Good heatlh and well-being | en_US |
| dc.description.sdg | SDG-09: Industry, innovation and infrastructure | en_US |
| dc.description.sponsorship | Telix Pharmaceuticals is providing IP and, along with the Oncidium Foundation, clinical and operational support. | en_US |
| dc.description.uri | https://ejhi.springeropen.com/ | en_US |
| dc.identifier.citation | Tually, P., Quinto, V.G., Omar, Y., Novruzov, F., Yudistiro, R., Sathekge, M., Currie, G., Galette, P., Patel, N., Brown, T., Bolland, G., Lo, Bue R. & Cade, D. Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry. EJNMMI Reports 2024 Dec 30; 8(1): 43. doi: 10.1186/s41824-024-00226-4. | en_US |
| dc.identifier.issn | 3005-074X (online) | |
| dc.identifier.other | 10.1186/s41824-024-00226-4 | |
| dc.identifier.uri | http://hdl.handle.net/2263/100805 | |
| dc.language.iso | en | en_US |
| dc.publisher | SpringerOpen | en_US |
| dc.rights | © The Author(s) 2024. Open Access. This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | en_US |
| dc.subject | 99mTc-HYNIC-iPSMA | en_US |
| dc.subject | SPECT | en_US |
| dc.subject | Tc-99m-iPSMA | en_US |
| dc.subject | Prostate cancer | en_US |
| dc.subject | SDG-03: Good health and well-being | en_US |
| dc.subject | SDG-09: Industry, innovation and infrastructure | en_US |
| dc.subject | Positron emission tomography/computed tomography (PET/CT) | en_US |
| dc.subject | Prostate-specific membrane antigen (PSMA) | en_US |
| dc.title | Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection : interim results from the global NOBLE registry | en_US |
| dc.type | Article | en_US |
